Isoray shareholders approve charter amendment to increase authorized shares; merger with Viewpoint on track

Perspective Therapeutics, Inc.

Shareholders approved amendment to increase authorized common shares to 750,000,000.
Vote: 71,844,322 for (50.55% of outstanding), 14,571,252 against, 948,682 abstain, 16,492,269 broker non-votes.
Removal of share cap clears a key condition for the pending merger with Viewpoint Molecular Targeting.
Merger expected to close in the near future.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Perspective Therapeutics, Inc. shareholders approved Approve an amendment to the Company’s Certificate of Incorporation to increase the total number of authorized shares of Common Stock to 750,000,000 at the 2023-01-27 meeting.

Proposal: charter amendment
Outcome: passed
Meeting: 2023-01-27

Exact text from the filing

The votes for this proposal were: For Against Abstain Broker Non-Votes 71,844,322 14,571,252 948,682 16,492,269

View on SEC.gov

444 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Perspective Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-23-002010

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.